Logo image
Dove: Shoulder-Based Opioid Overdose Detection and Reversal Device
Conference proceeding   Open access

Dove: Shoulder-Based Opioid Overdose Detection and Reversal Device

Anush Lingamoorthy, Amanda Watson, Korey Henderson, Ayan Mandal, David Gordon, Xiaonan Ma, James Weimer, Nagarajan Kandasamy and Jacob S. Brenner
IEEE International Conference on Connected Health: Applications, Systems and Engineering Technologies (CHASE)
01 Jan 2023
url
https://doi.org/10.1145/3580252.3586973View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

Computer Science, Cybernetics Computer Science, Interdisciplinary Applications Engineering, Biomedical Life Sciences & Biomedicine Science & Technology Computer Science Engineering Medical Informatics Technology
Naloxone is a life-saving drug capable of reversing a fatal opioid overdose. Although this drug has existed for over 50 years, opioid overdose-related deaths have consistently risen and surpassed 120,000 globally in 2021. Opioids induce respiratory depression by activating mu-opioid receptors at specific sites in the central nervous system. This results in overdose deaths caused by slow and shallow breathing, also known as opioid-induced respiratory depression. 1.6 million individuals suffer from opioid use disorder annually, making them at high risk of overdose, primarily due to the increasing prevalence of Fentanyl. Over 52% of these deaths occur when the individual is alone. Immediate response to an overdose by delivering naloxone can save the individual's life. To solve this problem, we developed a closed-loop sensor-driven auto-injector that can determine a fatal overdose and inject naloxone. 76% of this population is willing to wear such a device on the shoulder, a canonical injection site. This paper presents the DOVE, a shoulder-based opioid overdose detection and reversal device. It noninvasively measures the subject's motion state and changes in blood oxygen levels (SpO(2)) along with the respiration state. These biomarkers are measured from the shoulder using an optical sensor and accelerometer to determine if a fatal overdose occurred. We evaluated our DOVE device against an FDA-cleared commercial pulse oximeter by inducing apneic events as they have very similar SpO(2) trends to an overdose. Results show that SpO(2) can be measured on the shoulder across different skin tones with an accuracy of 96.8% and a high Pearson correlation of 0.766 (p < 0.0001).

Metrics

15 Record Views
2 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Computer Science, Cybernetics
Computer Science, Interdisciplinary Applications
Engineering, Biomedical
Medical Informatics
Logo image